Rapid Evolution of 6-Phenylpurine Inhibitors of Protein Kinase B Through Structure-Based DesignDonald, A., Mchardy, T., Rowlands, M.G., Hunter, L.J., Davies, T.G., Berdini, V., Boyle, R.G., Aherne, G.W., Garrett, M.D., Collins, I.
(2007) J Med Chem 50: 2289
- PubMed: 17451235
- DOI: https://doi.org/10.1021/jm0700924
- Primary Citation of Related Structures:
2UVX, 2UVY, 2UVZ, 2UW0
- PubMed Abstract:
6-phenylpurines were identified as novel, ATP-competitive inhibitors of protein kinase B (PKB/Akt) from a fragment-based screen and were rapidly progressed to potent compounds using iterative protein-ligand crystallography with a PKA-PKB chimeric protein. An elaborated lead compound showed cell growth inhibition and effects on cellular signaling pathways characteristic of PKB inhibition.